VG LIFE SCIENCES INC. RESTATEMENT AND AMENDMENT OF UNSECURED NOTE UNSECURED NOTEWarrant Agreement • June 20th, 2014 • VG Life Sciences, Inc. • Pharmaceutical preparations • California
Contract Type FiledJune 20th, 2014 Company Industry JurisdictionFOR VALUE RECEIVED, VG Life Sciences Inc., a Delaware corporation formerly known as Viral Genetics, Inc., whose address is 121 Gray Ave., Suite 200, Santa Barbara, CA 93101, (“Borrower”), promises to pay to or to the order of Best Investment Trust., a California entity (“Lender”), and its successors and assigns, in lawful money of the United States of America, Nine Hundred Ninety Three Thousand and Twenty Three ($993,023.00) (the “Principal”), with five (5%) interest per annum. No additional amounts may be tendered hereunder except as mutually agreed to in writing by Borrower and Lender. This Note is issued as a restatement and amendment of the Secured Revolving Credit Note dated March 5, 2008 issued by Borrower to Best Investment Inc. and subsequently assigned to Lender, to which such Note additional amounts have been tendered and owe.
VG LIFE SCIENCES INC. UNSECURED NOTEWarrant Agreement • June 20th, 2014 • VG Life Sciences, Inc. • Pharmaceutical preparations • California
Contract Type FiledJune 20th, 2014 Company Industry JurisdictionFOR VALUE RECEIVED, VG Life Sciences Inc., a Delaware corporation formerly known as Viral Genetics, Inc., whose address is 121 Gray Ave., Suite 200, Santa Barbara, CA 93101, (“Borrower”), promises to pay to or to the order of Mary Sinanyan a California residence (“Lender”), and its successors and assigns, in lawful money of the United States of America, Sixty Three Thousand Six Hundred Seventy Five Dollars and Fifty Five Cents ($63,675.55) (the “Principal”), with five (5%) interest per annum. No additional amounts may be tendered hereunder except as mutually agreed to in writing by Borrower and Lender.